PMID: 6985719Jan 1, 1980Paper

Sodium valproate: pharmacokinetics and effectivensss in treating intractable seizures

Neurology
J E RedenbaughH J Kupferberg

Abstract

Sodium valproate (VPA) was first marketed in the United States in 1978. In this pilot study of pharmacokinetics and toxicity, VPA was added to the treatment regimens of 20 patients (10 adults and 10 children) with intractable seizures. The drug was absorbed and excreted rapidly; the mean half-life was 9.6 hours. Drowsiness and gastrointestinal symptoms were the most common side effects, but they were usually minor and transient. An increase in some plasma phenobarbital levels and a decrease in some plasma phenytoin levels were attributed to drug interaction. Control of absence attacks was assessed by 12-hour telemetered electroencephalograms. Sodium valproate was most efficacious in generalized seizure disorders, particularly absence seizures.

Citations

Jun 19, 1992·Pharmaceutisch Weekblad. Scientific Edition·F Pisani
Jan 1, 1982·Progress in Neurobiology·A ChapmanJ C Vernieres
Jan 1, 1985·General Pharmacology·C Almodovar-CuevasP Garzón
Mar 20, 1980·The New England Journal of Medicine·J Koch-Weser, T R Browne
Jan 1, 1984·Epilepsia·D Schmidt
Jan 1, 1988·Epilepsia·B F Bourgeois
Jun 1, 1984·Italian Journal of Neurological Sciences·E ScanabissiR Calivà
May 1, 1985·Postgraduate Medical Journal·D R Lisk, S H Greene
Jun 1, 1984·Gut·P R Powell-JacksonR Williams
Aug 29, 1981·British Medical Journal·J Egger, E M Brett
Apr 1, 1983·Journal of Clinical Pharmacology·E KingsleyR Tweedale
Jan 1, 1983·Acta Neurologica Scandinavica. Supplementum·T Keränen, J Sivenius
Apr 1, 1993·Clinical EEG (electroencephalography)·X Wu, J J Ma
Dec 31, 1997·Neurology·C P PanayiotopoulosA Agathonikou
Sep 10, 2020·JIMD Reports·Laura María Palomino PérezConsuelo Pedrón-Giner
Oct 1, 1982·Scottish Medical Journal·J K McQueenJ K Brown
Aug 1, 1984·Acta Neurologica Scandinavica·H DinesenM Dam

❮ Previous
Next ❯

Related Concepts

Related Feeds

Absence Epilepsy

Absence epilepsy is a common seizure disorder in children which can produce chronic psychosocial sequelae. Discover the latest research on absence epilepsies here.